Tranzyme Pharma (TZYM) to Present TZP-102 Data at American Diabetes Association June 8-12, 2012 in Philadelphia, PA  
6/7/2012 9:52:37 AM

RESEARCH TRIANGLE PARK, N.C., June 6, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that Niels Ejskjaer, M.D., Ph.D., Department of Medicine MEA (Endocrinology and Diabetes) Aarhus University Hospital, Aarhus Denmark will present a poster entitled TZP-102 Ghrelin Receptor Agonist Improves Symptoms of Diabetic Gastroparesis in Both Type 1 and Type 2 Diabetes, at the American Diabetes Association's 72nd Scientific Sessions taking place at the Pennsylvania Convention Center, Philadelphia, PA from June 8-12, 2012. The general poster session is scheduled for Saturday, June 9, 2012 at 11:30 am ET, and the poster will be showcased as part of a Guided Audio Poster Tour on Monday, June 11, 2012 at 1:00 pm ET.